We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYN icon
14501
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$95 ﹤0.01%
11
-41,283
-100% -$362K
TRIB
14502
PUT
Trinity Biotech
TRIB
$7.88M
$94 ﹤0.01%
+1
New +$155
ALGS icon
14503
PUT
Aligos Therapeutics
ALGS
$43M
$87 ﹤0.01%
4
VWE
14504
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$83 ﹤0.01%
78
-48,909
-100% -$101K
PLM.RT
14505
DELISTED
PolyMet Mining Corp Rights (expiring April 4, 2023)
PLM.RT
$79 ﹤0.01%
+29,394
New +$491
NAVB
14506
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$78 ﹤0.01%
300
+100
+50% +$29
TRVN
14507
DELISTED
Trevena, Inc.
TRVN
$76 ﹤0.01%
+4
New +$130
BTTX
14508
PUT
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$73 ﹤0.01%
100
-86,600
-100% -$102K
FLNT
14509
Fluent
FLNT
$129M
$71 ﹤0.01%
15
-815
-98% -$6.36K
ONCR
14510
PUT
DELISTED
Oncorus, Inc.
ONCR
$69 ﹤0.01%
200
-500
-71% -$187
FBRX icon
14511
Forte Biosciences
FBRX
$1.57B
$68 ﹤0.01%
3
-180
-98% -$4.53K
ROOT icon
14512
Root
ROOT
$797M
$68 ﹤0.01%
15
-7,179
-100% -$36.4K
TKAT
14513
PUT
DELISTED
Takung Art Co., Ltd.
TKAT
$63 ﹤0.01%
100
TBIO
14514
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$62 ﹤0.01%
+1
New +$35
AUMN
14515
PUT
DELISTED
Golden Minerals Company
AUMN
$61 ﹤0.01%
12
-36
-75% -$229
AQB icon
14516
PUT
AquaBounty Technologies
AQB
$7.67M
$59 ﹤0.01%
5
-1,355
-100% -$21.8K
PRSO icon
14517
PUT
Peraso
PRSO
$10.3M
$55 ﹤0.01%
3
-50
-94% -$1.56K
CDAK
14518
PUT
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$52 ﹤0.01%
+300
New +$167
FCF icon
14519
First Commonwealth Financial
FCF
$2.18B
$50 ﹤0.01%
4
-34,736
-100% -$501K
MNTS icon
14520
Momentus
MNTS
$91.2M
-1
Closed -$10.1K
PLSE icon
14521
Pulse Biosciences
PLSE
$3.18B
$44 ﹤0.01%
13
-24,552
-100% -$74K
BBBY
14522
DELISTED
Bed Bath & Beyond Inc
BBBY
$38 ﹤0.01%
88
-1,215,708
-100% -$2.51M
MBIO icon
14523
PUT
Mustang Bio
MBIO
$4.5M
0
BIOC
14524
PUT
DELISTED
Biocept, Inc.
BIOC
$34 ﹤0.01%
3
-4
-57% -$58
SLDB icon
14525
CALL
Solid Biosciences
SLDB
$986M
$28 ﹤0.01%
+6
New +$36

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.